MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.hroo.2025.07.009

Медицинская библиотека · Heart rhythm O2 · 2025

Simplified left cardiac sympathetic denervation as an acute strategy for recurrent ventricular tachycardia in multimorbid patients with structural heart disease: A case series.

Krieger Konstantin, Park Innu, Kemper Thomas, Lösel Christoph, Schädlich Beate, Spittler Raphael, Kirchhöfer Maren, Lohrenz Christina, Meierling Stefan, Hoffmann Boris Alexander

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Cardiac sympathetic denervation as a treatment for drug-refractory ventricular arrhythmias (VAs) involves video-assisted thoracoscopic removal of the stellate ganglion (SG) and thoracic ganglia. A simplified approach sparing the SG and targeting left T2-T4 ganglia (left cardiac sympathetic denervation [LCSD]) may offer a less invasive alternative.

OBJECTIVE

This study aimed to evaluate the efficacy and safety of simplified SG-sparing LCSD as a bailout procedure for multimorbid patients with structural heart disease and recurrent VAs refractory to antiarrhythmic drugs and/or catheter ablation.

METHODS

All patients undergoing SG-sparing LCSD at our institution between June 2023 and June 2024 were included in this single-center retrospective study. Baseline demographics, procedural complications, and arrhythmia outcomes were analyzed.

RESULTS

LCSD was performed in 7 patients (mean age 75.9 ± 6.7 years, mean LVEF 30.7 ± 10.9%) with structural heart disease (nonischemic cardiomyopathy, n = 3; ischemic cardiomyopathy, n = 4) mostly 1 day (interquartile range 1-21) after admission with a procedure duration of 20.7 ± 5.3 minutes. Initially, 4 patients (57.1%) had electrical storm. Apart from 1 pleural effusion requiring drainage, no major complications or Horner's syndrome occurred. During a follow-up of 7 ± 2.6 months, median VA episodes requiring implantable cardioverter-defibrillator therapy decreased from 14 to 2 (P = .021) and median implantable cardioverter-defibrillator shocks from 1.5 to 0 (P = .034). Three patients remained free of sustained VAs; 1 patient died of coronavirus disease 2019.

CONCLUSION

In this case series of 7 patients, SG-sparing LCSD demonstrated promising results in terms of safety and efficacy for reducing VAs. Further studies are warranted to confirm long-term outcomes with this approach.

Для цитирования: Krieger Konstantin, Park Innu, Kemper Thomas, Lösel Christoph, Schädlich Beate, Spittler Raphael, Kirchhöfer Maren, Lohrenz Christina, Meierling Stefan, Hoffmann Boris Alexander. Simplified left cardiac sympathetic denervation as an acute strategy for recurrent ventricular tachycardia in multimorbid patients with structural heart disease: A case series.. Heart rhythm O2. 2025. DOI: 10.1016/j.hroo.2025.07.009.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.